DCM Shriram Fine Chemicals Limited Stock Analysis

The company remained profitable in Q3 FY2026 with revenue from operations of Rs. 9,695 lakhs, PBT of Rs. 161 lakhs, and PAT of Rs. 87 lakhs despite a challenging margin profile. / For the nine months ended December 31, 2025, total revenue reached Rs. 29,490 lakhs and PAT was Rs. 1,476 lakhs, showing the business has generated positive earnings over the broader period. / Interest coverage of 7x suggests finance costs are currently manageable, supported by low quarterly finance cost of Rs. 23 lakhs. / Total equity stood at Rs. 19,754 lakhs with reserves and surplus of Rs. 18,024 lakhs, indicating a reasonable equity base after the scheme of arrangement. / The actual loss on disposal of Dahej leasehold land was lower than estimated, allowing reversal of Rs. 223 lakhs of excess impairment provision and cleaning up a previously held-for-sale asset.

Q3 profitability was weak, with PAT of only Rs. 87 lakhs on total revenue of Rs. 9,759 lakhs, translating to a net profit margin of just 0.89%. / Earnings quality is mixed because reported profit was aided by a Rs. 223 lakhs reversal of excess impairment provision on land disposal, which is non-recurring in nature. / The effective tax rate was high at 45.96% in Q3 FY2026, with tax expense of Rs. 74 lakhs against PBT of Rs. 161 lakhs, which constrained net earnings. / The business is concentrated in a single segment, Organics and Fine Chemicals, and geographically in India, increasing dependence on one product line and one market. / Critical financial-health data such as operating cash flow, free cash flow, capex, working capital, current ratio, and debt levels were not disclosed in the extracted data, limiting visibility on liquidity and cash conversion. / Q3 earnings momentum appears weaker than the nine-month average, as PAT of Rs. 87 lakhs in the quarter is well below the nine-month PAT run-rate implied by Rs. 1,476 lakhs over nine months.

The company remained profitable in Q3 FY2026 with revenue from operations of Rs. 9,695 lakhs, profit before tax of Rs. 161 lakhs, and profit after tax of Rs. 87 lakhs. / Nine-month performance was meaningfully stronger than the standalone quarter, with total revenue of Rs. 29,490 lakhs and profit after tax of Rs. 1,476 lakhs for the nine months ended December 31, 2025. / Balance sheet support appears reasonable from the reported equity base of Rs. 19,754 lakhs, including reserves and surplus of Rs. 18,024 lakhs, with book value per share at Rs. 22.82. / Financing burden is low based on finance costs of only Rs. 23 lakhs in the quarter and interest coverage of 7x, suggesting debt servicing is currently manageable. / The actual loss on disposal of the Dahej leasehold land was lower than estimated, leading to a Rs. 223 lakhs reversal of excess impairment provision and reducing the drag from a non-core asset exit. / The company completed a major strategic reorganization during the year, with the chemical undertaking transfer bringing net assets of Rs. 15,336 lakhs and surplus of Rs. 28,663 lakhs under the scheme of arrangement.

Quarterly profitability is thin, with profit after tax of only Rs. 87 lakhs on total revenue of Rs. 9,759 lakhs, resulting in a net profit margin of just 0.89%. / Earnings quality is mixed because the quarter included a Rs. 223 lakhs reversal of excess impairment provision related to the Dahej land disposal, which is non-recurring and not core operating income. / Tax burden was high in Q3, with tax expense of Rs. 74 lakhs on profit before tax of Rs. 161 lakhs, implying a tax rate of 45.96% and limiting net earnings conversion. / The business is highly concentrated, with a single primary segment in Organics and Fine Chemicals and geographic revenue distribution limited to India. / Cost structure leaves little room for error, with cost of materials at Rs. 5,475 lakhs, employee cost at Rs. 1,204 lakhs, other expenses at Rs. 2,709 lakhs, and total expenses of Rs. 9,598 lakhs against total revenue of Rs. 9,759 lakhs. / Key financial visibility gaps remain because operating cash flow, free cash flow, liquidity ratios, debt levels, working capital metrics, and capex data are all not provided in the report extract.

Successfully completed Composite Scheme of Arrangement with DCM Shriram Industries resulting in transfer of net assets worth Rs. 15,336 lakhs and surplus of Rs. 28,663 lakhs, strengthening the balance sheet with total equity of Rs. 19,754 lakhs / Achieved profitable asset disposal during the quarter by selling leasehold land in Dahej, Gujarat, with actual loss lower than estimated leading to reversal of Rs. 223 lakhs excess impairment provision / Maintained healthy interest coverage ratio of 7x with finance costs of only Rs. 23 lakhs, indicating low financial leverage and minimal debt servicing burden / Successfully listed equity shares on BSE and NSE on February 17, 2026, providing improved liquidity and access to capital markets for future growth initiatives / Book value per share stands at Rs. 22.82 against face value of Rs. 2, reflecting substantial net worth accumulation and providing downside protection to equity holders

Extremely weak profitability with net profit margin of just 0.89% and quarterly PAT of Rs. 87 lakhs on revenue of Rs. 9,759 lakhs, indicating severe margin compression and operational inefficiency / Exceptionally high effective tax rate of 45.96% (Rs. 74 lakhs tax on Rs. 161 lakhs PBT) significantly eroding post-tax profitability and shareholder returns / Single segment dependence on Organics and Fine Chemicals manufacturing with single manufacturing location at Daurala, Meerut, creating concentration risk and operational vulnerability / Complete absence of critical financial metrics including cash flow data, debt levels, working capital, capex, ROE, ROCE, and YoY growth comparisons limiting transparency and investment visibility / High employee cost intensity at Rs. 1,204 lakhs (12.3% of revenue) combined with cost of materials at Rs. 5,475 lakhs (56.5% of revenue) leaving minimal operating leverage / Regulatory uncertainty from new Labour Codes consolidating 29 existing laws requiring ongoing monitoring for potential impact on employee benefit obligations and cost structure

Interest coverage ratio of 7x indicates adequate debt servicing capability with finance costs of only Rs. 23 lakhs against operational earnings, suggesting manageable leverage levels / Successful disposal of non-core leasehold land in Dahej, Gujarat resulted in reversal of Rs. 223 lakhs excess impairment provision, indicating better-than-expected asset realization / Completion of Composite Scheme of Arrangement with transfer of net assets worth Rs. 15,336 lakhs and surplus of Rs. 28,663 lakhs strengthens the balance sheet with total equity at Rs. 19,754 lakhs and book value per share of Rs. 22.82 / Nine-month cumulative performance (April-December 2025) shows stronger trajectory with total revenue of Rs. 29,490 lakhs and PAT of Rs. 1,476 lakhs translating to EPS of Rs. 1.70, significantly better than Q3 standalone performance / Focused single-segment operations in Organics and Fine Chemicals manufacturing at Daurala, Meerut facility provides operational simplicity and concentrated management attention

Extremely weak Q3 net profit margin of 0.89% with PAT of only Rs. 87 lakhs on revenue of Rs. 9,759 lakhs indicates severe margin pressure and operational inefficiency / Abnormally high effective tax rate of 45.96% (Rs. 74 lakhs tax on Rs. 161 lakhs PBT) substantially above standard corporate tax rates, suggesting tax inefficiencies or non-deductible expenses eroding shareholder returns / Complete absence of cash flow data prevents assessment of operating cash generation, free cash flow sustainability, and ability to fund capex or service obligations without external financing / High cost of materials at Rs. 5,475 lakhs (56.4% of total revenue) combined with employee costs of Rs. 1,204 lakhs and other expenses of Rs. 2,709 lakhs leaves minimal operating leverage for margin expansion / Missing critical financial metrics including ROE, ROCE, current ratio, debt-to-equity, working capital, and inventory turnover ratios prevent comprehensive evaluation of operational efficiency and financial health / New Labour Codes effective November 21, 2025 create regulatory uncertainty with potential future impact on employee benefit obligations and cost structure, though currently assessed as immaterial